Skip to main content
. 2023 May 4;14(7):e00592. doi: 10.14309/ctg.0000000000000592

Table 3.

Immunoassays that measure glycosylation-related changes in CRC

Assay GlycoEpitope Changes in CRC Clinical utility
CEA (150152) CD66 family of glycoproteins Elevated in certain cases of CRC Limited or no utility
CA19-9 (153155) Sialyl-LewisA Elevated in metastatic CRC Limited or no utility
CA-125 (156158) Heavily O-glycosylated MUC16 Unclear or mixed results May be useful for prognostication

CEA, carcinoembryonic antigen; CRC, colorectal cancer; MUC16, Mucin-16.